Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01508156
What this trial is testing

Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 130
Large-scale testing (Phase 3)Study completedNCT03067129
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 129
Testing effectiveness (Phase 2)UnknownNCT02028429
What this trial is testing

Efficacy of Sildenafil in the Improvement of Cognition and Quality of Life in Patients With Cirrhosis of Liver. A Proof of Concept Study.

Who this might be right for
Hepatic Encephalopathy.
Post Graduate Institute of Medical Education and Research, Chandigarh 50
Large-scale testing (Phase 3)Study completedNCT00410202
What this trial is testing

Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus

Who this might be right for
Hepatitis B, Chronic
Bristol-Myers Squibb 629
Not applicableNot Yet RecruitingNCT06178302
What this trial is testing

DEscripitive Patient Analysis to Enable Risk-based Quality Improvement Measures in a lArge iNternal mediCIne grouP Practice

Who this might be right for
Liver DysfunctionThyroidAtherosclerosis+3 more
Imed19 1,000
Not applicableUnknownNCT03310502
What this trial is testing

Variation of Genes Controlling Carbohydrate and Lipid Metabolism

Who this might be right for
Diabetes Mellitus, Type 2Cardiovascular DiseasesObesity+3 more
Turku University Hospital 2,050
Large-scale testing (Phase 3)Study completedNCT00844402
What this trial is testing

Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis

Who this might be right for
Primary Biliary CirrhosisHypercholesterolemia
Medical University of Graz 40
Not applicableStudy completedNCT06086002
What this trial is testing

Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 20
Large-scale testing (Phase 3)Study completedNCT01229839
What this trial is testing

Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 668
Post-approval studies (Phase 4)UnknownNCT01056172
What this trial is testing

PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)

Who this might be right for
Chronic Hepatitis C
Pusan National University Yangsan Hospital 164
Large-scale testing (Phase 3)Study completedNCT01014845
What this trial is testing

Clinical Trial of Recombinant Hepatitis E Vaccine

Who this might be right for
Hepatitis E
Xiamen University 112,604
Testing effectiveness (Phase 2)Study completedNCT00511095
What this trial is testing

Open-Label Study of the Safety and Immunogenicity of HEPLISAV™ Hepatitis B Virus Vaccine

Who this might be right for
Hepatitis B
Dynavax Technologies Corporation 207
Testing effectiveness (Phase 2)UnknownNCT03116945
What this trial is testing

Novel Gallium Imaging in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Rutgers, The State University of New Jersey 18
Not applicableUnknownNCT05609695
What this trial is testing

Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma

Who this might be right for
Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
Sun Yat-sen University 100
Not applicableStudy completedNCT03088995
What this trial is testing

Pilot Study of HIV and Hepatitis B and C Screening in Surgery

Who this might be right for
HIV InfectionsHepatitis BHepatitis C
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT03489239
What this trial is testing

Entecavir to TAF Switch

Who this might be right for
Hepatitis B
Thomas Jefferson University 27
Early research (Phase 1)Study completedNCT02686372
What this trial is testing

TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Lion TCR Pte. Ltd. 13
Early research (Phase 1)Study completedNCT02069145
What this trial is testing

Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer

Who this might be right for
Hepatocellular CancerLiver Cancer
OncoMed Pharmaceuticals, Inc. 10
Not applicableLooking for participantsNCT05264051
What this trial is testing

MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

Who this might be right for
Liver Diseases
University of Chicago 1,200
Post-approval studies (Phase 4)UnknownNCT00216229
What this trial is testing

Twinrix Alternative Schedule Study

Who this might be right for
Antibody Response After Vaccination
IDEWE Occupational Health Services 400
Next Page